Chronic Kidney DiseaseFundingKidney DiseaseKidneysMedia ReleasesMolecular Endocrinology and PharmacologyMolecular MedicineNews & EventsResearch Area
$20M for biopharm DIMERIX to fund phase 3 trials for rare kidney disease
By Alicia Bienkowski | Chronic Kidney Disease, Funding, Kidney Disease, Kidneys, Media Releases, Molecular Endocrinology and Pharmacology, Molecular Medicine, News & Events, Research AreaBiopharmaceutical company, Dimerix (ASX: DXB), which is developing new treatments for types of inflammatory kidney and respiratory diseases, announced it has successfully raised $20 million to fund Phase 3 trials…
Epigenetics and Genomics LaboratoryMedia ReleasesMolecular Endocrinology and PharmacologyNews & Events
Dual win sees two Harry Perkins researchers awarded in 2020 Business Events Perth Aspire Awards
By Alicia Bienkowski | Epigenetics and Genomics Laboratory, Media Releases, Molecular Endocrinology and Pharmacology, News & EventsBusiness Events Perth, in partnership with the Harry Perkins Institute of Medical Research, is pleased to announce that the inaugural Harry Perkins Aspire Award has been presented to two applicants:…
LabMolecular Endocrinology and PharmacologyNews & EventsResearch
Australian drug chosen for global trial to treat COVID-19
By Alicia Bienkowski | Lab, Molecular Endocrinology and Pharmacology, News & Events, ResearchA drug developed by Perkins and UWA spinout company Dimerix will be used in a global trial to treat patients who have Acute Respiratory Distress Syndrome (ARDS) as a result…
Centre for Clinical Research in Emergency MedicineEmergency MedicineLungsMedia ReleasesNews & EventsResearchStatements
Game-changing study shows ‘hands off’ approach’ best to treat a collapsed lung
By Alicia Bienkowski | Centre for Clinical Research in Emergency Medicine, Emergency Medicine, Lungs, Media Releases, News & Events, Research, StatementsIt’s the basic rule of medicine all doctors follow – ‘first do no harm’. New research from a collaboration between Australian and New Zealand researchers backs that premise, showing that…
Advanced Clinical and Translational Cardiovascular ImagingCardiovascular DiseaseClinical ScienceDisease AreaLabNews & EventsResearchResearch Area
Can your gut bacteria affect your heart health?
By Marlin Communications | Advanced Clinical and Translational Cardiovascular Imaging, Cardiovascular Disease, Clinical Science, Disease Area, Lab, News & Events, Research, Research AreaThe study led by Professor Girish Dwivedi from the Harry Perkins Institute of Medical Research, as well as researchers from UWA and Curtin University reviewed evidence from a number of…
Centre for Diabetes ResearchClinical ScienceLabNews & EventsResearchResearch Area
Researchers developing tools to predict risk of fatal illness
By Marlin Communications | Centre for Diabetes Research, Clinical Science, Lab, News & Events, Research, Research AreaThe team from the Harry Perkins Institute of Medical Research’s Centre for Diabetes Research has been selected to develop their technology through the prestigious CSIRO ON Accelerate program. The project…
Centre for Diabetes ResearchClinical ScienceLabNews & EventsResearchResearch Area
Perth gene mine leads to international breakthrough
By Marlin Communications | Centre for Diabetes Research, Clinical Science, Lab, News & Events, Research, Research AreaA ‘Gene Mine’ developed by UWA Professor Grant Morahan at the Harry Perkins Institute of Medical Research has enabled a breakthrough in the fundamental understanding of chemical biology which will change the…
Centre for Diabetes ResearchClinical ScienceDiabetesDisease AreaLabNews & EventsResearchResearch Area
Perkins researchers find new way to defend against Type 2 Diabetes
By Marlin Communications | Centre for Diabetes Research, Clinical Science, Diabetes, Disease Area, Lab, News & Events, Research, Research AreaType 2 Diabetes affects 1.4 million Australians and is caused when insulin-producing cells stop functioning properly. Diabetes researcher, UWA Associate Professor Fang-Xu Jiang, said it had been established that people…
